EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 198 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,469,000 | +5.4% | 136,093 | +1.2% | 0.24% | +3.9% |
| Q3 2016 | $4,241,000 | +40.2% | 134,506 | +25.0% | 0.23% | +46.2% |
| Q2 2016 | $3,025,000 | -35.8% | 107,577 | -17.0% | 0.16% | -48.5% |
| Q1 2016 | $4,714,000 | +0.8% | 129,672 | +10.9% | 0.31% | +42.1% |
| Q4 2015 | $4,677,000 | +41.0% | 116,908 | +0.5% | 0.22% | -1.8% |
| Q3 2015 | $3,316,000 | -6.9% | 116,380 | +7.6% | 0.22% | -5.2% |
| Q2 2015 | $3,563,000 | -8.0% | 108,145 | -19.7% | 0.23% | -0.4% |
| Q1 2015 | $3,872,000 | -14.3% | 134,642 | -18.8% | 0.23% | -15.3% |
| Q4 2014 | $4,518,000 | +19.0% | 165,913 | -6.9% | 0.28% | +18.5% |
| Q3 2014 | $3,798,000 | -3.6% | 178,204 | +1.6% | 0.23% | -6.8% |
| Q2 2014 | $3,941,000 | +17.0% | 175,452 | +31.7% | 0.25% | +7.3% |
| Q1 2014 | $3,367,000 | +8.9% | 133,253 | -1.0% | 0.23% | +8.4% |
| Q4 2013 | $3,093,000 | +74.6% | 134,541 | +44.7% | 0.21% | +68.5% |
| Q3 2013 | $1,771,000 | – | 92,963 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |